Association of Metformin Use With End‐Stage Renal Disease in Patients With Type 2 Diabetes Mellitus: A Nationwide Cohort Study Under the Pay‐for‐Performance Program-Reference-Cited by-同舟云学术

Association of Metformin Use With End‐Stage Renal Disease in Patients With Type 2 Diabetes Mellitus: A Nationwide Cohort Study Under the Pay‐for‐Performance Program

Published:2019-06-04 Issue:11 Volume:59 Page:1443-1452
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Lee Ming‐Chia¹²,Lee Chih‐Hsin³⁴,Chang Lih‐Yu⁵,Chang Chia‐Hao⁵,Zhang Jun‐Fu⁶,Lee Meng‐Rui⁵⁶,Wang Jann‐Yuan⁶^ORCID,Chen Shih‐Ming²

Affiliation:

1. Department of PharmacyNew Taipei City Hospital New Taipei City Taiwan

2. School of PharmacyCollege of PharmacyTaipei Medical University Taipei Taiwan

3. Division of Pulmonary MedicineDepartment of Internal MedicineWan Fang HospitalTaipei Medical University Taipei Taiwan

4. Division of Pulmonary MedicineDepartment of Internal MedicineSchool of MedicineCollege of MedicineTaipei Medical University Taipei Taiwan

5. Department of Internal MedicineNational Taiwan University Hospital Hsin‐Chu Branch Hsin‐Chu Taiwan

6. Department of Internal MedicineNational Taiwan University Hospital Taipei Taiwan

Funder

Ministry of Health and Welfare

Ministry of Science and Technology, Taiwan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1452

Reference38 articles.

1. IDF Diabetes Atlas.8th ed. International Diabetes Federation;2017.http://www.idf.org/diabetesatlas. Accessed January 1 2019.

2. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease

3. The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic Review

4. Medical costs associated with type 2 diabetes complications and comorbidities;Li R;Am J Manag Care,2013

5. Irbesartan treatment of patients with type 2 diabetes, hypertension and renal disease: a UK health economics analysis

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Within and post-trial effects of an intensive lifestyle intervention on kidney disease in adults with overweight or obesity and type 2 diabetes mellitus: a secondary analysis of the Look AHEAD clinical trial;BMJ Open Diabetes Research & Care;2024-05

2. Metformin potentiates nephrotoxicity by promoting NETosis in response to renal ferroptosis;Cell Discovery;2023-10-17

3. Effects of metformin and intensive lifestyle interventions on the incidence of kidney disease in adults in the DPP/DPPOS;Journal of Diabetes and its Complications;2023-09

4. Bisphosphonate Use Is Not Associated With Tuberculosis Risk Among Patients With Osteoporosis: A Nationwide Cohort Study;The Journal of Clinical Pharmacology;2022-06-13

5. Metformin use and cardiovascular outcomes in patients with diabetes and chronic kidney disease: a nationwide cohort study;Kidney Research and Clinical Practice;2021-12-31